Results 71 to 80 of about 982,114 (278)

Investigating the cell of origin and novel molecular targets in Merkel cell carcinoma: a historic misnomer

open access: yesMolecular Oncology, EarlyView.
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian   +10 more
wiley   +1 more source

Automatic Post-Editing for Vietnamese

open access: yes, 2021
Accepted to ALTA ...
Vu, Thanh, Nguyen, Dai Quoc
openaire   +2 more sources

Measuring post-editing time and effort for different types of machine translation errors [PDF]

open access: yes, 2016
Post-editing (PE) of machine translation (MT) is becoming more and more common in the professional translation setting. However, many users refuse to employ MT due to bad quality of the output it provides and even reject post-editing job offers.
Corpas Pastor, Gloria   +3 more
core  

Towards Optimizing MT for Post-Editing Effort: Can BLEU Still Be Useful? [PDF]

open access: yes, 2017
We propose a simple, linear-combination automatic evaluation measure (AEM) to approximate post-editing (PE) effort. Effort is measured both as PE time and as the number of PE operations performed. The ultimate goal is to define an AEM that can be used to
Esplà-Gomis, Miquel   +3 more
core   +2 more sources

YAP1::TFE3 mediates endothelial‐to‐mesenchymal plasticity in epithelioid hemangioendothelioma

open access: yesMolecular Oncology, EarlyView.
The YAP1::TFE3 fusion protein drives endothelial‐to‐mesenchymal transition (EndMT) plasticity, resulting in the loss of endothelial characteristics and gain of mesenchymal‐like properties, including resistance to anoikis, increased migratory capacity, and loss of contact growth inhibition in endothelial cells.
Ant Murphy   +9 more
wiley   +1 more source

Decisions in projects using machine translation and post-editing

open access: yesJoSTrans: The Journal of Specialised Translation
Machine translation (MT) and post-editing (PE) have become increasingly important in the professional language industry in recent years. However, not every translation job is suitable for MT and there are many options for carrying out translation/post ...
Jean Nitzke   +3 more
doaj   +1 more source

Modeling hepatic fibrosis in TP53 knockout iPSC‐derived human liver organoids

open access: yesMolecular Oncology, EarlyView.
This study developed iPSC‐derived human liver organoids with TP53 gene knockout to model human liver fibrosis. These organoids showed elevated myofibroblast activation, early disease markers, and advanced fibrotic hallmarks. The use of profibrotic differentiation medium further amplified the fibrotic signature seen in the organoids.
Mustafa Karabicici   +8 more
wiley   +1 more source

Translating in the Cloud Age: Online Marketplaces

open access: yesHermes, 2017
This article explores the influence of cloud computing on translation, including professional translation. Cloud computing reshapes the management of labour in ways that unsettle the traditional relations between managers and workers.
Ignacio Garcia
doaj   +1 more source

An empirical study of segment prioritization for incrementally retrained post-editing-based SMT [PDF]

open access: yes, 2015
Post-editing the output of a statistical machine translation (SMT) system to obtain high-quality translation has become an increasingly common application of SMT, which henceforth we refer to as post-editing-based SMT (PE-SMT).
Ankit, Srivastava   +4 more
core  

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

open access: yesMolecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy